Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles For Members Only Top Hedge Funds Are Reshaping Their Portfolios Stephen Taub Emerging Markets Are an Unlikely Winner of the AI Boom John Crabb What’s Really Moving Commodity Markets in 2026? Sponsored by CME Group